Oliviero James F III

CIK 00014347183 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001434718

Recent Transactions

50 trades

Gift
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-12-20−900,000→ 2,294,583 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-12-19$3.38/sh−220,230→ 3,194,583 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-12-18$3.87/sh−602,167→ 3,414,813 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-12-13+2,077,700→ 4,016,980 total
Gift
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-06-26−37,890→ 1,939,280 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-06-26$2.05/sh−24,610→ 1,977,170 total
Award
Nuvectis Pharma, Inc.$NVCT
Common Stock
2024-06-13+30,000→ 57,828 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2024-05-24+1,660,000→ 2,001,780 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-02-28$2.06/sh−5,894→ 350,836 total
Gift
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-02-28−9,056→ 341,780 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-02-01$2.01/sh−11,900→ 369,680 total
Gift
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-02-01−12,950→ 356,730 total
Gift
Checkpoint Therapeutics, Inc.
Common Stock
2023-08-16−12,510→ 381,580 total
Award
Nuvectis Pharma, Inc.$NVCT
Common Stock
2023-06-16+18,000→ 27,828 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2023-03-31+250,000→ 394,090 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2023-03-02$5.00/sh−5,483→ 144,090 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2023-02-27$4.65/sh−5,548→ 134,573 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2023-02-27+15,000→ 149,573 total
Gift
Checkpoint Therapeutics, Inc.
Common Stock
2023-02-24−42,000→ 381,580 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2023-02-01$4.77/sh−10,261→ 182,121 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2023-01-10$6.75/sh−3,817→ 192,382 total
Gift
Checkpoint Therapeutics, Inc.
Common Stock
2022-09-26−60,000→ 196,199 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-06-23$1.11/sh−15,000→ 2,562,003 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-06-22$1.09/sh−12,000→ 2,577,003 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-06-21$1.09/sh−21,000→ 2,589,003 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-06-17$1.09/sh−228,000→ 2,610,003 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-04-13$1.51/sh−21,258→ 2,838,003 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-04-05$1.77/sh−14,030→ 2,859,261 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-04-04$1.79/sh−86,353→ 2,873,291 total
Award
Nuvectis Pharma, Inc.$NVCT
Stock Options (right to buy)
2022-04-01+15,000→ 15,000 total
Tax Payment
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-02-24$1.85/sh−117,657→ 2,959,644 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2022-01-31+455,000→ 3,608,210 total
Tax Payment
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-01-30$2.46/sh−31,972→ 3,077,301 total
Tax Payment
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-01-24$2.19/sh−143,136→ 3,109,273 total
Tax Payment
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-01-06$2.77/sh−53,024→ 3,252,409 total
Tax Payment
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-01-01$3.11/sh−302,777→ 3,305,433 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2021-02-05$3.42/sh−48,790→ 3,153,210 total
Sale
Checkpoint Therapeutics, Inc.
COMMON STOCK
2021-02-04$3.51/sh−70,000→ 3,202,000 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2021-01-06+539,000→ 3,272,000 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2020-02-24+598,000→ 2,733,000 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2019-01-24+485,000→ 2,135,000 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK (RESTRICTED)
2018-01-30+325,000→ 1,650,000 total
Sale
KERYX BIOPHARMACEUTICALS INC
Common Stock
2015-01-05$13.79/sh−5,604→ 171,616 total
Award
KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
2015-01-04+47,750→ 47,750 total
Award
KERYX BIOPHARMACEUTICALS INC
Common Stock
2015-01-04+23,875→ 177,220 total
Sale
KERYX BIOPHARMACEUTICALS INC
Common Stock
2014-01-03$12.57/sh−6,309→ 492,861 total
Award
KERYX BIOPHARMACEUTICALS INC
Common Stock
2014-01-02+22,741→ 499,170 total
Award
KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
2014-01-02+53,062→ 53,062 total
Sale
KERYX BIOPHARMACEUTICALS INC
Common Stock
2013-04-05$6.93/sh−1,484→ 588,205 total
Sale
KERYX BIOPHARMACEUTICALS INC
Common Stock
2012-01-03$2.63/sh−7,190→ 182,018 total

Companies

Recent Filings

Address

2 GANSEVOORT ST, 9TH FLOOR

NEW YORK, NY, 10014

View on SEC.gov